Prostaglandin FP receptor inhibitor reduces ischemic brain damage and neurotoxicity

Neurobiology of Disease

Volumn 48, Issue 1, 2012, Pages 58-65

  Kim, Yun Tai ^a   Moon, Sang Kwan ^b   Maruyama, Takayuki ^c   Narumiya, Shuh ^d   Doré, Sylvain ^e  

^a Korea Food Research Institute   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

^c ONO PHARMACEUTICAL CO   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e UNIVERSITY OF FLORIDA   (United States)

Author keywords

Cerebral ischemia; Inflammation; Oxygen glucose deprivation; Receptor; Stroke

Indexed keywords

11 FLUORO 9,15 DIHYDROXY 15 (2 INDANYL) 16,17,18,19,20 PENTANORPROSTA 5,13 DIENOIC ACID; CALCIUM; PROSTAGLANDIN F RECEPTOR; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; REACTIVE OXYGEN METABOLITE; RYANODINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL DEATH; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CALCIUM; CELL DEATH; CELLS, CULTURED; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, KNOCKOUT; NEURONS; NEUROPROTECTIVE AGENTS; REACTIVE OXYGEN SPECIES; RECEPTORS, PROSTAGLANDIN;

EID: 84863737794     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2012.06.003     Document Type: Article

References (31)

1. Abramovitz M., Boie Y., Nguyen T., Rushmore T.H., Bayne M.A., Metters K.M., Slipetz D.M., Grygorczyk R. Cloning and expression of a cDNA for the human prostanoid FP receptor. J. Biol. Chem. 1994, 269:2632-2636.
2. Ahmad A.S., Kim Y.T., Ahmad M., Maruyama T., Doré S. Selective blockade of PGE2 EP1 receptor protects brain against experimental ischemia and excitotoxicity, and hippocampal slice cultures against oxygen-glucose deprivation. Neurotox. Res. 2008, 14:343-351.
3. Bano D., Nicotera P. Ca2+ signals and neuronal death in brain ischemia. Stroke 2007, 38:674-676.
4. Berliocchi L., Bano D., Nicotera P. Ca2+ signals and death programmes in neurons. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2005, 360:2255-2258.
5. Besancon E., Guo S., Lok J., Tymianski M., Lo E.H. Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke. Trends Pharmacol. Sci. 2008, 29:268-275.
6. Brennan A.M., Suh S.W., Won S.J., Narasimhan P., Kauppinen T.M., Lee H., Edling Y., Chan P.H., Swanson R.A. NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat. Neurosci. 2009, 12:857-863.
7. Carlson N.G. Neuroprotection of cultured cortical neurons mediated by the cyclooxygenase-2 inhibitor APHS can be reversed by a prostanoid. J. Neurosci. Res. 2003, 71:79-88.
8. Chemtob S., Beharry K., Rex J., Varma D.R., Aranda J.V. Prostanoids determine the range of cerebral blood flow autoregulation of newborn piglets. Stroke 1990, 21:777-784.
9. Doré S. GPCR antagonists as an alternative to COX-2 inhibitors: a case for the PGE2 EP1 receptor. Trends Pharmacol. Sci. 2006, 27:458-460.
10. Dore S., Otsuka T., Mito T., Sugo N., Hand T., Wu L., Hurn P.D., Traystman R.J., Andreasson K. Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction. Ann. Neurol. 2003, 54:155-162.
11. Echeverria V., Greenberg D.L., Dore S. Expression of prostaglandin E2 synthases in mouse postnatal cortical neurons. Ann. N. Y. Acad. Sci. 2005, 1053:460-471.
12. Hayashi T., Saito A., Okuno S., Ferrand-Drake M., Dodd R.L., Chan P.H. Damage to the endoplasmic reticulum and activation of apoptotic machinery by oxidative stress in ischemic neurons. J. Cereb. Blood Flow Metab. 2005, 25:41-53.
13. Kawano T., Anrather J., Zhou P., Park L., Wang G., Frys K.A., Kunz A., Cho S., Orio M., Iadecola C. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat. Med. 2006, 12:225-229.
14. Kim Y.T., Namkung Y.L., Kwak J., Suh C.K. Involvement of Na+-Ca2+ exchanger on metabotropic glutamate receptor 1-mediated [Ca2+]i transients in rat cerebellar Purkinje neurons. Neuroscience 2007, 146:170-177.
15. Kitanaka J., Hasimoto H., Sugimoto Y., Negishi M., Aino H., Gotoh M., Ichikawa A., Baba A. Cloning and expression of a cDNA for rat prostaglandin F2 alpha receptor. Prostaglandins 1994, 48:31-41.
16. Moskowitz M.A., Lo E.H., Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 2010, 67:181-198.
17. Muralikrishna Adibhatla R., Hatcher J.F. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic. Biol. Med. 2006, 40:376-387.
18. Newcomb-Fernandez J.K., Zhao X., Pike B.R., Wang K.K., Kampfl A., Beer R., DeFord S.M., Hayes R.L. Concurrent assessment of calpain and caspase-3 activation after oxygen-glucose deprivation in primary septo-hippocampal cultures. J. Cereb. Blood Flow Metab. 2001, 21:1281-1294.
19. Oga T., Matsuoka T., Yao C., Nonomura K., Kitaoka S., Sakata D., Kita Y., Tanizawa K., Taguchi Y., Chin K., Mishima M., Shimizu T., Narumiya S. Prostaglandin F(2alpha) receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-beta. Nat. Med. 2009, 15:1426-1430.
20. Saleem S., Li R.C., Wei G., Dore S. Effects of EP1 receptor on cerebral blood flow in the middle cerebral artery occlusion model of stroke in mice. J. Neurosci. Res. 2007, 85:2433-2440.
21. Saleem S., Zhuang H., Biswal S., Christen Y., Dore S. Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury. Stroke 2008, 39:3389-3396.
22. Saleem S., Ahmad A.S., Maruyama T., Narumiya S., Dore S. PGF(2alpha) FP receptor contributes to brain damage following transient focal brain ischemia. Neurotox. Res. 2009, 15:62-70.
23. Saleem S., Kim Y.T., Maruyama T., Narumiya S., Doré S. Reduced acute brain injury in PGE2 EP3 receptor-deficient mice after cerebral ischemia. J. Neuroimmunol. 2009, 208:87-93.
24. Saleem S., Shah Z.A., Urade Y., Doré S. Lipocalin-prostaglandin D synthase is a critical beneficial factor in transient and permanent focal cerebral ischemia. Neuroscience 2009, 160:248-254.
25. Simard J.M., Chen M., Tarasov K.V., Bhatta S., Ivanova S., Melnitchenko L., Tsymbalyuk N., West G.A., Gerzanich V. Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nat. Med. 2006, 12:433-440.
26. Snetkov V.A., Knock G.A., Baxter L., Thomas G.D., Ward J.P., Aaronson P.I. Mechanisms of the prostaglandin F2alpha-induced rise in [Ca2+]i in rat intrapulmonary arteries. J. Physiol. 2006, 571:147-163.
27. Takayama K., Yuhki K., Ono K., Fujino T., Hara A., Yamada T., Kuriyama S., Karibe H., Okada Y., Takahata O., Taniguchi T., Iijima T., Iwasaki H., Narumiya S., Ushikubi F. Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia. Nat. Med. 2005, 11:562-566.
28. Wahlgren N.G., Ahmed N. Neuroprotection in cerebral ischaemia: facts and fancies-the need for new approaches. Cerebrovasc. Dis. 2004, 17(Suppl. 1):153-166.
29. Xu W., Chou C.L., Sun H., Fujino H., Chen Q.M., Regan J.W. FP prostanoid receptor-mediated induction of the expression of early growth response factor-1 by activation of a Ras/Raf/mitogen-activated protein kinase signaling cascade. Mol. Pharmacol. 2008, 73:111-118.
30. Zhen G., Kim Y.T., Li R.C., Yocum J., Kapoor N., Langer J., Dobrowolski P., Maruyama T., Narumiya S., Dore S. PGE(2) EP1 receptor exacerbated neurotoxicity in a mouse model of cerebral ischemia and Alzheimer's disease. Neurobiol. Aging. 2012, 33:2215-2219.
31. Zhou P., Qian L., Chou T., Iadecola C. Neuroprotection by PGE2 receptor EP1 inhibition involves the PTEN/AKT pathway. Neurobiol. Dis. 2008, 29:543-551.